Authors:
BOLAJI II
MORTIMER G
GRIMES H
TALLON DF
ODWYER E
FOTTRELL PF
Citation: Ii. Bolaji et al., CLINICAL-EVALUATION OF NEAR-CONTINUOUS ORAL MICRONIZED PROGESTERONE THERAPY IN ESTROGENIZED POSTMENOPAUSAL WOMEN, Gynecological endocrinology, 10(1), 1996, pp. 41-47
Authors:
WINGFIELD M
OHERLIHY C
FINN MM
TALLON DF
FOTTRELL PF
Citation: M. Wingfield et al., FOLLICULAR AND LUTEAL-PHASE SALIVARY PROGESTERONE PROFILES IN WOMEN WITH ENDOMETRIOSIS AND INFERTILITY, Gynecological endocrinology, 8(1), 1994, pp. 21-25
Authors:
ORORKE A
KANE MM
GOSLING JP
TALLON DF
FOTTRELL PF
Citation: A. Ororke et al., DEVELOPMENT AND VALIDATION OF A MONOCLONAL-ANTIBODY ENZYME-IMMUNOASSAY FOR MEASURING PROGESTERONE IN SALIVA, Clinical chemistry, 40(3), 1994, pp. 454-458
Citation: Ii. Bolaji et al., ASSESSMENT OF BIOAVAILABILITY OF ORAL MICRONIZED PROGESTERONE USING ASALIVARY PROGESTERONE ENZYME-IMMUNOASSAY, Gynecological endocrinology, 7(2), 1993, pp. 101-110